Used primarily as a reference standard in pharmaceutical quality control, this impurity compound plays a critical role in the analysis and purification of Imatinib, a tyrosine kinase inhibitor used in cancer treatment. It helps in identifying degradation products and monitoring the stability of Imatinib formulations during storage and manufacturing. Its presence is closely studied to ensure drug purity, safety, and regulatory compliance. Additionally, it supports method development in analytical techniques such as HPLC and LC-MS for accurate detection of impurities in active pharmaceutical ingredients.